Additional file 1 of Alterations of plasma circulating microRNAs in BALB/c mice with Toxocara canis visceral and cerebral larva migrans

Supplementary material 1. Table S1. The primers used in the PCR-based molecular identification of Toxocara canis and quantification of microRNAs. Table S2. Identification and prediction of microRNAs in the infective larvae of Toxocara canis. Table S3. Differential expression analysis of microRNAs between serum-treated and -untreated infective larvae of Toxocara canis. Table S4. Plasma EV-containing preparations-encapsulated microRNAs mapped to the genome of Mus musculus or Toxocara canis. Table S5. Toxocara canis-derived microRNAs detected in the plasma EV-containing preparations of infected mice. Table S6. Functional enrichment analysis for genes targeted by Toxocara canis miRNAs in the infected mice. Table S7. Toxocara canisinfection-induced microRNA alterations in mice at three days post infection. Table S8. Toxocara canisinfection-induced microRNA alterations in mice at four days post infection. Table S9. Toxocara canisinfection-induced microRNA alterations in mice at 21 days post infection. Table S10.Functional enrichment analysis for genes targeted by Toxocara canisinfection induced differential miRNAs in mice. Table S11. Potential microRNA biomarkers for Toxocarainfection in mice.